Nasal high-flow preoxygenation for endotracheal intubation in the critically ill patient: a randomized clinical trial

ConclusionsCompared with SMO, preoxygenation with HFNC in the ICU did not improve the lowest SpO2 during intubation in the non-severely hypoxemic patients but led to a reduction in intubation-related adverse events.Trial registrationClinical trial Submission: 7 March 2016. Registry name: Benefits of high-flow nasal cannulae oxygen for preoxygenation during intubation in non-severely hypoxemic patients: the PROTRACH study. Clinicaltrials.gov identifier: NCT02700321. Eudra CT: 2015-A00145-44. CPP: 15/13-975 (Comit é de protection des personnes de Rennes). URL registry:https://clinicaltrials.gov/ct2/show/record/NCT02700321.
Source: Intensive Care Medicine - Category: Intensive Care Source Type: research